Myocardial fibrosis in primary aldosteronism

Myocardial fibrosis in primary aldosteronism

ObjectiveWe investigated myocardial fibrosis in relation to clinical and biochemical characteristics and the metabolomics in patients with primary aldosteronism.MethodsOur study included 54 patients with primary aldosteronism. We performed cardiac magnetic resonance to evaluate focal replacement myo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi-Lin Chen, Chi-Hua Chen, Xiao-Fei Ye, Jian-Zhong Xu, Li-Min Zhu, Ting-Yan Xu, Yan Li, Ji-Guang Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Endocrinology
Subjects:	primary aldosteronism myocardial fibrosis late gadolinium enhancement extracellular volume metabolomic analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1567876/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of Myocardial Fibrosis in Endurance Athletes: A Systematic Review
by: Rasha Kaddoura, et al.
Published: (2025-01-01)

Novel insights into myocardial fibrosis in patients with new onset ST-elevation myocardial infarction following percutaneous coronary intervention through enhanced cardiac magnetic resonance imaging: a prospective cohort study
by: Temilola J. Oketunbi, et al.
Published: (2025-04-01)

Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy
by: Xin-Yi Feng, et al.
Published: (2025-01-01)

Accelerated myocardial fibrosis in young to middle-aged patients with hypertrophic cardiomyopathy
by: Shiro Nakamori, et al.
Published: (2024-01-01)

Amyloid cardiomyopathy: сlinical significance and diagnostic value of magnetic resonance imaging
by: M. V. Ezhikova, et al.
Published: (2024-11-01)

Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
by: S A. Aleksandrova, et al.
Published: (2024-12-01)

Remote myocardial fibrosis predicts adverse outcome in patients with myocardial infarction on clinical cardiovascular magnetic resonance imaging
by: Nicholas Black, et al.
Published: (2024-01-01)

Determinants of myocardial fibrosis in patients with immune-mediated inflammatory diseases
by: Nicholas Black, et al.
Published: (2025-06-01)

Cardiac T1 mapping in non-ST-segment elevation myocardial infarction: temporal changes in myocardial fibrosis
by: Luis Paiva, et al.
Published: (2025-05-01)

Predictive role of quantification of myocardial fibrosis using delayed contrast-enhanced magnetic resonance imaging in nonischemic dilated cardiomyopathies: a systematic review and meta-analysis
by: E Z Golukhova, et al.
Published: (2022-01-01)

Myocardial fibrosis and atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-09-01)

Evaluation of myocardial fibrosis and wall motion abnormality with 68Ga-FAPI PET/MR in coronary heart disease
by: Rui Luo, et al.
Published: (2025-07-01)

Multiparametric cardiovascular magnetic resonance is associated with outcomes in pediatric heart transplant recipients
by: Andrew A. Lawson, et al.
Published: (2025-01-01)

Comparison of Dual-Energy CT Derived Myocardial Delayed Enhancement with Magnetic Resonance Imaging in Patients with Cardiomyopathy-Related Heart Failure
by: Damandeep Singh, et al.

Effect of aldosterone on collagen formation markers in patients with myocardial infarction and renal dysfunction
by: K .V. Tashchuk, et al.
Published: (2018-07-01)

Development and Validation of Imaging‐Free Myocardial Fibrosis Prediction Models, Association with Outcomes, and Sample Size Estimation for Phase 3 Trials
by: Nicholas Black, et al.
Published: (2025-04-01)

Evaluation of subclinical myocardial involvement in systemic lupus erythematosus using multiparametric cardiac magnetic resonance imaging
by: Lingling Huang, et al.
Published: (2025-08-01)

Effect of obesity on myocardial tissue characteristics in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance-based study
by: Jie Wang, et al.
Published: (2025-01-01)

Features of myocardial characteristics of patients with acute ST-segment elevation myocardial infarction with diabetes mellitus as assessed by contrast-enhanced cardiac magnetic resonance imaging
by: O. V. Stukalova, et al.
Published: (2023-08-01)

Impaired hemodynamic forces assessed by routine CMR and its determinants in different duration T2DM patients with normal LV function and myocardial strain
by: Guozhu Shao, et al.
Published: (2025-01-01)

Late gadolinium enhancement cardiovascular magnetic resonance with generative artificial intelligence
by: Omer Burak Demirel, et al.
Published: (2025-01-01)

SERUM ALDOSTERONE LEVEL DYNAMICS AND CARDIAC REMODELING IN MYOCARDIAL INFARCTION PATIENTS WITH UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA TREATED WITH SELECTIVE ALDOSTERONE RECEPTOR BLOCKER
by: E. P. Miroshnichenko, et al.
Published: (2018-09-01)

Late gadolinium-enhanced cardiovascular magnetic resonance for predicting left ventricular reverse remodeling in dilated cardiomyopathy: A comprehensive review and meta-analysis
by: Yaqiong Zhou, et al.
Published: (2025-01-01)

The association between aldosterone and lipid profiles in patients with primary aldosteronism
by: Ning-Peng Liang, et al.
Published: (2025-03-01)

Effect of eplerenone on aldosterone and von Willebrand factor levelsin patients with myocardial infarction and chronic kidney disease
by: V. K. Tashchuk, et al.
Published: (2022-02-01)

Ex-vivo validation of nine algorithms for quantifying infarcts with late gadolinium enhancement cardiovascular magnetic resonance
by: Sascha Kopic, et al.
Published: (2025-01-01)

Myocardial remodeling and arterial stiffness depending on aldosterone level in patients with chronic kidney disease and arterial hypertension
by: O. V. Kuryata, et al.
Published: (2019-12-01)

Effect of plasma aldosterone concentration on serum uric acid metabolism
by: WEI Yushuang, et al.
Published: (2025-02-01)

Effect of Age on Aldosterone–Renin Ratio in Screening Primary Aldosteronism
by: Ning Peng, et al.
Published: (2025-03-01)

Role of magnetic resonance imaging in the detection of myocardial fibrosis in life-threatening ventricular arrhythmias
by: V. E. Oleinikov, et al.
Published: (2023-08-01)

ALDOSTERONE LEVELS AND HEART REMODELING IN MYOCARDIAL INFARCTION PATIENTS WITH NON-DIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA
by: E. P. Miroshnichenko, et al.
Published: (2016-11-01)

Myocardial Damage Patterns in Patients with Left Ventricular Systolic Dysfunction with and Without Coronary Artery Disease Referred for Cardiac Magnetic Resonance
by: Justyna M. Sokolska, et al.
Published: (2025-07-01)

Multimodality Imaging in the Diagnosis and Assessment of Cardiac Amyloidosis
by: Jyothirmayi Velaga, et al.
Published: (2022-09-01)

Role of late gadolinium enhancement in the risk stratification of pediatric hypertrophic cardiomyopathy: based on a Chinese cohortResearch in context
by: Xingrui Chen, et al.
Published: (2025-05-01)

GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: V. A. lonin, et al.
Published: (2015-04-01)

Association between cardiac dysfunction and late gadolinium enhancement confined to the LV intramural region in patients with hypertrophic cardiomyopathy
by: Zhi Yang, et al.
Published: (2025-12-01)

Predictors of prognosis by cardiac magnetic resonance imaging in patients with idiopathic restrictive heart disease
by: Ahmed Shawky Asfour, et al.
Published: (2025-06-01)

Clinical Diagnostic Workflow of Nondilated Left Ventricular Cardiomyopathy: A Case-based Review
by: Priya Chudgar, et al.
Published: (2024-07-01)

Specific Premature Ventricular Complex Characteristics in Women: Insights from a Patient Cohort
by: Ștefan Ailoaei, et al.
Published: (2025-05-01)

The associations among genetic features, late gadolinium enhancement and prognosis in hypertrophic cardiomyopathy
by: Wenhua Su, et al.
Published: (2025-07-01)